MYC and posterior cortical atrophy: Moreover, the endogenous protein Cancer Inhibitor of PP2A (CIP2A) has been reported to be highly expressed and involved in PCa progression via c-MYC regulation [9,10], and CIP2A knockdown is able to resensitize metastatic castration-resistant PCa cells to cabazitaxel [11].